Unaudited Preliminary Results

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces its preliminary results for the year ended 31 December 2017, a pivotal year where the Company expanded into the larger clinical ultrasound software market. Financial highlights Revenues increased 27% to £4.2m (2016: £3.3m North America sales double to £1.7m Rest of World sales up 44% to £1.8m, with 83% growth for sales into China Raised £5.4m net of costs by way of placing of shares Year-end cash at £4.3m (2016: £1.8m) Operational highlights Acquired Intelligent Ultrasound Limited bringing artificial intelligence expertise to the Group Won UK Government [...]

March 21st, 2018|

Notice of Results

Investor results presentation MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces it will be reporting its final results for the year ended 31 December 2017 on Wednesday, 21 March 2018. Investor briefing Stuart Gall (CEO), Wilson Jennings (FD) and Nicholas Sleep (CTO) will be hosting a briefing for investors on Wednesday, 21 March from 3.30pm to 5pm at the offices of IP Group. There will be an opportunity to see live demonstrations of a number of MedaPhor’s products, including ScanTrainer, HeartWorks and the newly launched BodyWorks simulator platforms, as well as demonstrations of the new [...]

March 5th, 2018|